Skip to search formSkip to main contentSkip to account menu

Apazone

Known as: 5-(Dimethylamino)-9-methyl-2-propyl-1H-pyrazolo(1,2-a)(1,2,4)benzotriazine-1,3(2H)-dione, 1H-Pyrazolo(1,2-a)(1,2,4)benzotriazine-1,3(2H)-dione, 5-(dimethylamino)-9-methyl-2-propyl-, Apazone [Chemical/Ingredient] 
An anti-inflammatory agent used in the treatment of rheumatoid arthritis. It also has uricosuric properties and has been used to treat gout.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
This study compared the effects of azapropazone and indomethacin plus allopurinol in the management of acute gout and… 
1983
1983
Eight patients with acute gouty arthritis were treated with high dose oral azapropazone 600 mg qds in an open study in order to… 
1981
1981
1 The free fraction of azapropazone in the plasma of 37 healthy volunteers ranged from 0.0027 to 0.0070 (0.0044 +/- 0.0009, mean… 
1981
1981
A patient is reported who developed a hitherto unrecognized drug interaction between azapropazone and anticonvulsants which led… 
1981
1981
A double-blind, crossover trial was carried out to assess the clinical efficacy of 3.6 g aspirin, 1200 mg azapropazone and the… 
1976
1976
In an open assessment of azapropazone, 51 patients with rheumatoid disorders, mainly rheumatoid arthritis, were treated… 
1976
1976
Azapropazone was investigated in a 2-week double-blind clinical out-patient trial against placebo in 23 patients with definite… 
1976
1976
A double-blind crossover trial in 50 patients with rheumatoid arthritis was carried out to compare the clinical effectiveness of… 
1976
1976
SummaryA double-blind crossover study in 41 patients with knee joint osteoarthrosis was carried out to compare the efficacy of… 
1974
1974
SummaryAzapropazone, a new non-steroidal anti-inflammatory drug, was investigated in a single-blind, crossover clinical out…